<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04262453</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02373-52</org_study_id>
    <nct_id>NCT04262453</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract</brief_title>
  <acronym>SAOS-K</acronym>
  <official_title>Obstructive Sleep Apnea Syndrome In Patients Treated For Cancer Of The Upper Aerodigestive Tract : The SAOS-K Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Sud Francilien</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Sud Francilien</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence
      and severity of sleep apnea syndrome in patients treated for cancer of the upper
      aerodigestive tract.

      The patient follows a usual course of care including, at the end of the treatment of his
      cancer of the upper aerodigestive tract, screening for obstructive sleep apnea syndrome at 3
      months and 6 months (Epworth score and ventilatory polygraphy)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective open-label, non-randomized, monocentric, cohort study, to assess the prevalence
      and severity of sleep apnea syndrome in patients treated for cancer of the upper
      aerodigestive tract.

      Patients are included in the study when they are hospitalized for panendoscopy. Thereafter,
      it takes about 1 month to start any treatment. The duration of treatment is estimated at
      about 5 months (the longest regimen would be induction chemotherapy followed by surgery and
      adjuvant complementary treatment). After which the patient follows a usual course of care
      including, at the end of the treatment of his cancer of the upper aerodigestive tract,
      screening for obstructive sleep apnea syndrome at 3 months and 6 months (Epworth score and
      ventilatory polygraphy).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 21, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Occurence of obstructive sleep apnea syndrome</measure>
    <time_frame>3 months after the end of treatment for cancer of the upper aerodigestive tract</time_frame>
    <description>Obstructive sleep apnea syndrome is defined by an apnea-hypopnea index greater than or equal to 15 per hour</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Delay in onset of obstructive sleep apnea syndrome after completion of cancer treatment</measure>
    <time_frame>during the 6 months follow-up</time_frame>
    <description>Delay in onset of obstructive sleep apnea syndrome after completion of cancer treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Epworth score</measure>
    <time_frame>at 3 months and 6 months</time_frame>
    <description>The Epworth auto-questionnaire, rated from 0 (better) to 24 (worse), assess day-time sleapiness.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurence of obstructive sleep apnea syndrome</measure>
    <time_frame>6 months after the end of treatment for cancer of the upper aerodigestive tract</time_frame>
    <description>Obstructive sleep apnea syndrome is defined by an apnea-hypopnea index greater than or equal to 15 per hour</description>
  </secondary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Upper Aerodigestive Tract Neoplasms</condition>
  <condition>Obstructive Sleep Apnea-hypopnea Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients with a recently discovered upper aerodigestive tract tumour who have not yet
        started treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  macroscopic lesion suggestive of a cancerous tumour of the upper aerodigestive tract
             (oral cavity, oropharynx, larynx, hypopharynx, cavum, cervical lymph node metastases
             with an occult primary cancer)

          -  awaiting anatomopathological confirmation

        Exclusion Criteria:

          -  history of cancer of the upper aerodigestive tract

          -  history of known obstructive sleep apnea syndrome

          -  cancer of the thyroid, salivary glands, nose and paranasal sinuses

          -  patients under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandrine Baron, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Sud Francilien</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elodie Henry, CRU manager</last_name>
    <phone>+33161693730</phone>
    <email>elodie.henry@chsf.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Sud Francilien</name>
      <address>
        <city>Corbeil-Essonnes</city>
        <zip>91106</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elodie Henry, CRU manager</last_name>
      <phone>+33161693730</phone>
      <email>elodie.henry@chsf.fr</email>
    </contact>
    <investigator>
      <last_name>Sandrine Baron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Didier Salvan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Im√®ne Gharzouli, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Georges Abitbol, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <results_reference>
    <citation>Huyett P, Kim S, Johnson JT, Soose RJ. Obstructive sleep apnea in the irradiated head and neck cancer patient. Laryngoscope. 2017 Nov;127(11):2673-2677. doi: 10.1002/lary.26674. Epub 2017 May 23.</citation>
    <PMID>28543072</PMID>
  </results_reference>
  <results_reference>
    <citation>Gilat H, Shpitzer T, Guttman D, Soudry E, Feinmesser R, Bachar G. Obstructive sleep apnea after radial forearm free flap reconstruction of the oral tongue. Laryngoscope. 2013 Dec;123(12):3223-6. doi: 10.1002/lary.24125. Epub 2013 Apr 10.</citation>
    <PMID>23575744</PMID>
  </results_reference>
  <results_reference>
    <citation>Loth A, Michel J, Giorgi R, Santini L, Rey M, Elbaum JM, Roux N, Giovanni A, Dessi P, Fakhry N. Prevalence of obstructive sleep apnoea syndrome following oropharyngeal cancer treatment: A prospective cohort study. Clin Otolaryngol. 2017 Dec;42(6):1281-1288. doi: 10.1111/coa.12869. Epub 2017 Apr 18.</citation>
    <PMID>28332763</PMID>
  </results_reference>
  <results_reference>
    <citation>Faiz SA, Balachandran D, Hessel AC, Lei X, Beadle BM, William WN Jr, Bashoura L. Sleep-related breathing disorders in patients with tumors in the head and neck region. Oncologist. 2014 Nov;19(11):1200-6. doi: 10.1634/theoncologist.2014-0176. Epub 2014 Oct 1.</citation>
    <PMID>25273079</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 9, 2019</study_first_submitted>
  <study_first_submitted_qc>February 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 10, 2020</study_first_posted>
  <last_update_submitted>February 7, 2020</last_update_submitted>
  <last_update_submitted_qc>February 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Upper Aerodigestive Tract Neoplasms</keyword>
  <keyword>Obstructive Sleep Apnea-hypopnea Syndrome</keyword>
  <keyword>Epworth score</keyword>
  <keyword>Ventilatory Polygraphy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

